noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Karyopharm Therapeutics Inc.

PAK4 Inhibition Improves PD-1 Blockade Immunotherapy
Karyopharm Therapeutics Inc.

Selinexor in combination with carboplatin and paclitaxel in patients[...]
Karyopharm Therapeutics Inc.

Phase 1b study to evaluate the safety of selinexor in combination with[...]

Healthcare

Karyopharm Therapeutics Inc.

07/28/2022 | Press release | Archived content

Updated Efficacy of Eltanexor Monotherapy in Patients with Higher Risk Myelodysplastic Syndrome Primary Refractory to Hypomethylating Agents

Sharing and Personal Tools

Please select the service you want to use: